000 01430cam  2200325zi 4500
0019.919482
003CaOODSP
00520230411135437
006m     o  d f      
007cr cn|||||||||
008230125t20232023onca    o    f000 0 eng d
020 |a9780660472799
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aHP40-333/2023E-PDF
24500|aHIV anti-retroviral medication coverage in Canada : |bsummary.
264 1|a[Ottawa] : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |c2023.
264 4|c©2023
300 |a1 online resource (13 pages) : |billustrations
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Couverture des médicaments antirétroviraux contre le VIH au Canada : sommaire.
650 0|aHIV infections|xTreatment|zCanada.
650 0|aHealth insurance|zCanada.
7102 |aPublic Health Agency of Canada, |eissuing body.
77508|tCouverture des médicaments antirétroviraux contre le VIH au Canada : |w(CaOODSP)9.919484
85640|qPDF|s2.51 MB|uhttps://publications.gc.ca/collections/collection_2023/aspc-phac/HP40-333-2023-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/services/publications/diseases-conditions/summary-hiv-antiretroviral-medication-coverage.html